Results 51 to 60 of about 528,622 (127)

In vitro comparison of the adsorption of inflammatory mediators by blood purification devices

open access: yesIntensive Care Medicine Experimental, 2018
Background Septic shock, a leading cause of acute kidney injury, induces release of pro-/anti-inflammatory mediators, leading to increased mortality and poor renal recovery.
Benjamin Malard   +2 more
doaj   +1 more source

Adjunctive Hemoadsorption Therapy with CytoSorb in Patients with Septic/Vasoplegic Shock: A Best Practice Consensus Statement [PDF]

open access: yes, 2023
Hemoadsorption; Hyperinflammation; Septic shockHemoadsorción; Hiperinflamación; Shock sépticoHemoadsorció; Hiperinflamació; Shock sèpticA dysregulated host response is a common feature in critically ill patients due to both infectious and non-infectious ...
Nierhaus, Axel   +12 more
core   +1 more source

Cytosorb® hemoadsorption of apixaban during emergent cardio-pulmonary bypass: a case report.

open access: yes, 2020
Peri-operative coagulation management of patients receiving apixaban, a new oral anticoagulant, is difficult. The CytoSorb ® hemoadsorption device might represent a therapeutic option to reduce apixaban's pharmacological and inflammatory effects during ...
Mendes, V.   +23 more
core   +1 more source

Supplementary Material for: Rapid and effective elimination of myoglobin with CytoSorb® hemoadsorber in patients with severe rhabdomyolysis

open access: yes, 2023
Introduction: Rhabdomyolysis is characterized by destruction of muscle fibres by various causes, diagnosed by increased creatin kinase concentrations in the blood. Myoglobin released into the blood may cause acute kidney injury.
Fuchs M. (17290282)   +6 more
core   +1 more source

Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb®)—A case report

open access: yesClinical Case Reports, 2022
Rhabdomyolysis (RM) is a potentially life‐threatening entity that can lead to acute kidney injury (AKI). Continuous renal replacement therapy (CRRT) alone is known as effective therapy, but the additional use of a hemoadsorber (like CytoSorb®) might ...
Erich Moresco   +3 more
doaj   +1 more source

Reverse‐Engineered Lipid Nanoparticles Harness Protein Corona Formation for Cytokine Sequestration and Combination Immunomodulatory Therapy

open access: yesSmall, Volume 22, Issue 55, 1 October 2026.
Bioinspired triglyceride‐ceramide lipid nanoparticles were reverse‐engineered from cytokine‐sequestering plant‐derived nanoparticles to capture pathological inflammatory mediators through protein corona formation. Dexamethasone‐loaded TCNPs combine extracellular cytokine sequestration with intracellular immunomodulation, reducing IL‐6, TNF‐α, and NF‐κΒ
Junsik J. Sung   +2 more
wiley   +1 more source

Cardiac arrest as a manifestation of unknown Type V glycogenosis: a case report

open access: yesESC Heart Failure, 2022
Few cases have been reported to date, in which a massive rhabdomyolysis causes a cardiac arrest in a male adult suffering from undiagnosed McArdle disease.
Raquel Soria‐Navarro   +5 more
doaj   +1 more source

Immunomodulation by hemoadsorption

open access: yes, 2022
Background: Sepsis is often associated with liver dysfunction, which is an indicator of poor outcomes. Specific diagnostic tools that detect hepatic dysfunction in its early stages are scarce. So far, the immune modulatory effects of hemoadsorption with \
Henzler, Dietrich (Prof. Dr. med.)   +6 more
core   +1 more source

Evaluation of Hemoadsorption Capacity of the CytoSorb Adsorber for Toxic Doses of Diclofenac and Meloxicam in Porcine Plasma

open access: yesJournal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT The objective of this in vitro experimental was to determine the utility of hemoadsorption (HA) using the CytoSorb adsorber to remove meloxicam and diclofenac from porcine plasma. For this purpose 12 1‐L aliquots of porcine plasma, 6 units were spiked with 293 μg/mL (262–320 μg/mL) diclofenac and 6 with 42.8 μg/mL (41.4–44.7 μg/mL) meloxicam ...
Bettina Giani   +3 more
wiley   +1 more source

Successful use of haemoperfusion therapy in an adult horse with hepatic encephalopathy and cholangiohepatitis

open access: yesEquine Veterinary Education, Volume 38, Issue 6, Page e307-e314, June 2026.
Summary A 4‐year‐old, 520 kg, American Quarter Horse broodmare, approximately 90 days in foal, was presented to Texas A&M University Teaching Hospital for suspected liver disease. Based on clinicopathological values and hepatic abnormalities noted ultrasonographically, the mare was presumptively diagnosed with cholangiohepatitis.
A. C. Trimble   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy